Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

Epithelial ovarian cancer (EOC) is the most fatal gynaecological malignancy. Despite initial therapeutic response, the majority of advanced-stage patients relapse and succumb to chemoresistant disease. Overcoming drug resistance is the key to successful treatment of EOC. Members of vascular endothel...

Descripción completa

Detalles Bibliográficos
Autores principales: Momeny, Majid, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Moghaddaskho, Farima, Eyvani, Haniyeh, Yousefi, Hassan, Mirshahvaladi, Shahab, Poursani, Ensieh M., Barghi, Farinaz, Poursheikhani, Arash, Dardaei, Leila, Bashash, Davood, Ghazi-Khansari, Mahmoud, Tavangar, Seyyed M., Dehpour, Ahmad R., Yaghmaie, Marjan, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382685/
https://www.ncbi.nlm.nih.gov/pubmed/28383032
http://dx.doi.org/10.1038/srep45954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382685/
https://www.ncbi.nlm.nih.gov/pubmed/28383032
http://dx.doi.org/10.1038/srep45954

Ejemplares similares